Clarametyx Biosciences IPO

Clarametyx Biosciences is a developer of immune therapies in the replacement of antibiotics. With a mission to treat life-threatening infections and reduce antibiotic resistance, their platform works to protect bacteria with pathogen-agnostic biologic technology. Key focus areas of the company include clinical development of moderate to severe pneumonia and treatment for chronic diseases like cystic fibrosis. Clarametyx Biosciences was founded by Michael Triplett and Peter Kleinhenz in 2020 and is headquartered in Columbus, OH.

Register for Details

For more details on financing and valuation for Clarametyx Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Clarametyx Biosciences

Forge green plus iconForge green minus icon

What is Clarametyx Biosciences's IPO price?

The IPO price for Clarametyx Biosciences will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Clarametyx Biosciences?

Clarametyx Biosciences is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Clarametyx Biosciences shares pre-IPO?

If you own Clarametyx Biosciences pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Clarametyx Biosciences a publicly traded company?

Clarametyx Biosciences is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was Clarametyx Biosciences founded?

Clarametyx Biosciences was founded in 2019.

Who are Clarametyx Biosciences's major investors?

National Institutes of Health
Ohio Innovation Fund
JobsOhio Growth Capital Fund
Updated on: Jun 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.